[1]
J. E. Couto, PharmD, MBA, L. Webster, MD, FACPM, FASAM, M. C. Romney, MS, JD, MPH, H. L. Leider, MD, MBA, and A. Linden, DrPH, MS, “Use of an algorithm applied to urine drug screening to assess adherence to an OxyContin® regimen”, J of Opioid Management, vol. 5, no. 6, pp. 359–364, Jan. 2018.